Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region
Corresponding Author
Daniel L. Van Dyke Ph.D.
Medical Genetics Center, Henry Ford Hospital, Detroit, Michigan
Director of Cytogenetics, Henry Ford Hospital, Detroit, MI 48202, U.S.A.Search for more papers by this authorMaria J. Worsham
Medical Genetics Center, Henry Ford Hospital, Detroit, Michigan
Search for more papers by this authorTimothy Drumheller
Medical Genetics Center, Henry Ford Hospital, Detroit, Michigan
Search for more papers by this authorMichael S. Benninger
Department of Otolaryngology/Head and Neck Surgery, Henry Ford Hospital, Detroit, Michigan
Search for more papers by this authorCharles J. Krause
Cancer Research Laboratory, Department of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan
Search for more papers by this authorShan R. Baker
Cancer Research Laboratory, Department of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan
Search for more papers by this authorGregory T. Wolf
Cancer Research Laboratory, Department of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan
Search for more papers by this authorThomas E. Carey
Cancer Research Laboratory, Department of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan
Search for more papers by this authorBarbara C. Tilley
Division of Biostatistics and Research Epidemiology, Henry Ford Hospital, Detroit, Michigan
Search for more papers by this authorCorresponding Author
Daniel L. Van Dyke Ph.D.
Medical Genetics Center, Henry Ford Hospital, Detroit, Michigan
Director of Cytogenetics, Henry Ford Hospital, Detroit, MI 48202, U.S.A.Search for more papers by this authorMaria J. Worsham
Medical Genetics Center, Henry Ford Hospital, Detroit, Michigan
Search for more papers by this authorTimothy Drumheller
Medical Genetics Center, Henry Ford Hospital, Detroit, Michigan
Search for more papers by this authorMichael S. Benninger
Department of Otolaryngology/Head and Neck Surgery, Henry Ford Hospital, Detroit, Michigan
Search for more papers by this authorCharles J. Krause
Cancer Research Laboratory, Department of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan
Search for more papers by this authorShan R. Baker
Cancer Research Laboratory, Department of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan
Search for more papers by this authorGregory T. Wolf
Cancer Research Laboratory, Department of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan
Search for more papers by this authorThomas E. Carey
Cancer Research Laboratory, Department of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan
Search for more papers by this authorBarbara C. Tilley
Division of Biostatistics and Research Epidemiology, Henry Ford Hospital, Detroit, Michigan
Search for more papers by this authorAbstract
We characterized the breakpoints, gains, and losses of chromosome material in squamous cell carcinomas of the head and neck region from 29 patients. Cell lines were karyotyped in 1/3 of cases, direct preparations or early in vitro harvests in 1/3, and both in 1/3 of cases. GTG-banding was employed in all cases, as were C-banding and RBG- and AgNOR-staining in most. Some tumors were near-diploid and others near-tetraploid, but many had mixed populations, with diploid, tetraploid, and octoploid subclones representing essentially the same karyotypic pattern. The most frequent changes were deletions. Losses affecting 3p13-p24, 5q12-q23, 8p22-p23, 9p21 -p24, and 18q22-q23 ranged in frequency from 40% to 60% of tumors. Loss of the short arm of the inactive X occurred in 70% of tumors from female patients, and loss or rearrangement of the Y occurred in 74% of tumors from male patients. Loss of 18q appeared to be associated with short survival, as did the presence of multiple deletions. There was gain (2-5 extra copies) of 3q21 -qter, 5p, 7p, 8q, and 11q 13-q23 in 28-38% of tumors. Three tumors had an hsr involving 11q13-q21. Gain of material at 11q13 is postulated to be associated with amplification of the PRADI/CCND gene at that locus. A translocation between proximal 1 p and either an acrocentric short arm or proximal 8p or 9p was observed in squamous cell carcinomas of the head and neck region but not in female genital tract tumors. No other abnormalities appeared to be site specific, suggesting a pattern of genetic evolution in squamous cell carcinoma that is independent of anatomic site. Genes Chrom Cancer 9:192-206 (1994). © 1994 Wiley-Liss, Inc.
References
- Benninger MS (1992) Presentation and evaluation of patients with epidermoid head and neck cancers. Henry Ford Hosp Med J 40: 144–148.
- Berenson JR, Yang J, Mickel RA (1989) Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. Oncogene 4: 1111–1116.
- Boynton RF, Huang Y, Blount PL, Reid BJ, Raskind WH, Haggitt RC, Newkirk C, Resau JH, Yin J, McDaniel T, Meltzer SJ (1991) Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. Cancer Res 51: 5766–5769.
- Bradford CR, Kimmel KA, Van Dyke DL, Worsham MJ, Tilley BJ, Burk D, del Rosario F, Lutz S, Tooley R, Hayashida DJS, Carey TE (1991) 11p deletions and breakpoints in squamous cell carcinoma: Association with altered reactivity with the UM-E7 antibody. Genes Chrom Cancer 3: 272–282.
- Cann CI. Fried MP, Rothman KJ (1985) Epidemiology of squamous cell cancer of the head and neck. Otolaryngol Clin 18: 1–22.
- Carey TE, Van Dyke DL, Worsham MJ, Bradford CR, Babu VR, Schwartz DR, Hsu S, Baker SR (1989) Characterization of human laryngeal primary and metastatic squamous cell carcinoma cell lines USI-SCC-17A and UM-SCC-17B. Cancer Res 49: 6098–6107.
- Carey TE, Van Dyke DL, Worsham MJ, James CD, Kelker W (1993) Loss of 18q in clinically aggressive squamous cell carcinomas correlates with homozygosity for the DCC locus. Fifth International Workshop on Chromosomes in Solid Tumors, January10-12, 1993, Tucson, Arizona.
- Chatelain R, Hoffmeister B, Härk F, Böcking A, Mittermayer C (1989) DNA grading of oral squamous carcinomas. A preliminary report. Int J Oral Maxillofac Surg 18: 43–46.
- Cowan JM, Beckett MA, Ahmed-Swan S, Weichselbaum RR (1992) Cytogenetic evidence of the multistep origin of head and neck squamous cell carcinomas. J Natl Cancer Inst 84: 793–797.
- Diaz MO, LeBeau MM, Pitha P, Rowley JD (1986) Inteferon and c-ets-1 genes in the translocation (9;11) (p22;q23) in human acute monocytic leukemia. Science 231: 265–267.
- Dutrillaux B, Couturier J (1986) Chromosome imbalances in endometrial adenocarcinomas: A possible adaptation to abnormal metabolic pathways. Ann Genet 29: 76–81.
- Eisbruch A, Blick M, Lee JS, Sacks PG, Gutterman J (1987) Analysis of the epidermal growth factor receptor gene in fresh human head and neck cancers. Cancer Res 47: 3603–3605.
- Emi M, Fujiwara Y, Nakajima T, Tsuchiya E, Tsuda H, Hirohashi S, Maeda Y, Tsuruta K, Miyaki M, Nakamura Y (1992) Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res 52: 5368–5372.
- Epstein LB, Epstein CJ (1976) Localization of the gene AVG for the antiviral expression of immune and classical interferon to the distal portion of the long arm of chromosome 21. J Infect Dis 133 (Suppl): A56–A62.
- Fearon E, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, Vogelstein B (1990) Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247: 49–56.
- Grenman SE, Van Dyke DL, Worsham MJ, England B, McClatchey KD, Hopkins M, Babu VR, Grenman R, Carey TE (1990) Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new ER-negative vulvar carcinoma cell lines, UM-SCV-1A and UM-SCV-1B. Int J Cancer 45: 920–927.
- Heo DS, Snyderman C, Collin SM, Pan S, Walker E, Deka R, Barnes EL, Johnson JT, Herberman RB, Whiteside TL (1989) Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Res 49: 5167–5175.
- Hollstein MC, Smits AM, Galiana C, Yamasaki H, Bos JL, Mandard A, Partensky C, Montsanto R (1988) Amplification of growth factor receptor gene but no evidence of ras mutations in primary human esophageal cancers. Cancer Res 48: 5119–5123.
- Huang Y, Boynton RF, Blount PL, Silverstein RJ, Yin J, Tong Y, McDaniel TK, Newkirk C, Resau JH, Sridhara R, Reid BJ, Meltzer SJ (1992) Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res 52: 6525–6530.
- Itoh S, Harada H, Nakamura Y, White R, Taniguchi T (1991) Assignment of human interferon regulatory factor-1 (IRF) gene to chromosome 5q23-31. Genomics 10: 1097–1099.
- Jiang W, Kahn SM, Tomita N, Zhang YJ, Lu SH, Weinstein IB (1992) Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res 52: 2980–2983.
- Jin Y, Higashi K, Mandahl N, Heim S, Wennerberg J, Bioklund A, Dictor M, Mitelman F (1990) Frequent rearrangement of chromosomal bands 1p22 and 11q13 in squamous cell carcinomas of the head and neck. Genes Chrom Cancer 2: 198–204.
- Kern SE, Fearon ER, Tersmette KWF, Enterline JP, Leppert M, Nakamura Y, White R, Vogelstein B, Hamilton SR (1989) Allelic loss in colorectal carcinoma. JAMA 261: 3099–3103.
- Kitagawa Y, Ueda M, Ando N, Shinozawa Y, Shimizu N, Abe O (1991) Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma. Cancer Res 51: 1504–1508.
- Lafage M, Pedeutour F, Marchetto S, Simonetti J, Prosperi MT, Gaudray P, Birnbaum D (1992) Fusion and amplification of two originally non-syntenic chromosomal regions in a mammary carcinoma cell line. Genes Chrom Cancer 5: 40–49.
- Latif F, Fivash M, Glenn G, Tory K, Orcutt ML, Hampsch K, Dellisio J, Lerman M, Cowan J, Beckett M, Weichselbaum R (1992) Chromosome 3p deletions in head and neck carcinomas: Statistical ascertainment of allelic loss. Cancer Res 52: 1451–1456.
- Pejovic T, Heim S, Orndal C, Jin Y, Mandahl N, Willen H, Mitelman F (1990) Simple numerical chromosome aberrations in well-differentiated malignant epithelial tumors. Cancer Genet Cytogenet 49: 95–101.
- Roa RA, Carey TE, Passamani PP, Greenwood JH, Hsu S, Ridings EO, Schwartz DR, Wolf GT, Hudson JL (1985) DNA content of human squamous cell carcinoma cell lines. Arch Otolaryngol 111: 565–575.
- Schuuring E, Verhoven E, Meoi WJ, Michalides RJAM (1992) Identification and cloning of two overexpressed genes, U21B31/ PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7: 355–367.
- Somers KD, Cartwright SL, Schechter GL (1990) Amplification of the int-2 gene in human head and neck squamous cell carcinomas. Oncogene 5: 915–920.
- Somers KD, Merrick MA, Lopez ME, Incognito LS, Schechter GL, Casey G (1992) Frequent p53 mutations in head and neck cancer. Cancer Res 52: 5997–6000.
- Trent JM, Olson S, Lawn RM (1982) Chromosomal localization of human leukocyte, fibroblast and immune interferon genes by means of in situ hybridization. Proc Natl Acad Sci USA 79: 7809–7813.
- Van der Bosch K, Becker I, Savelyeva L, Brüderlein S, Schlag P, Schwab M (1992) Deletions in the short arm of chromosome 8 are present in up to 90% of human colorectal cancer cell lines. Genes Chrom Cancer 5: 91–95.
- Viegas-Pequignot E, Flury-Herard A, De Cremoux H, Chlecq C, Bignon J, Dutrillaux B (1990) Recurrent chromosome aberrations in human lung squamous cell carcinomas. Cancer Genet Cytogenet 49: 37–49.
- Vogelstein B, Fearon E, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, White R (1989) Allelotype of colorectal cancer. Science 244: 207–211.
- Wagata T, Ishizaki K, Imamura M, Shimada Y, Ikenaga M, Tobe T (1991) Deletion of 17p and amplification of the int-2 gene in esophageal carcinomas. Cancer Res 51: 2113–2117.
- Whang-Peng J, Banks-Schlegel SP, Lee EC (1990) Cytogenetic studies of esophageal carcinoma cell lines. Cancer Genet Cytogenet 45: 101–120.
- Whang-Peng J, Knudsen T, Gazdar A, Steinberg SM, Oie H, Linnoila I, Mulshine J, Nau M, Minna JD (1991) Nonrandom structural and numerical chromosome changes in non-small-cell lung cancer. Genes Chrom Cancer 3: 168–188.
- Worsham MJ, Van Dyke DL, Grenman SE, Grenman R, Hopkins MA, Roberts JA, Gasser KM, Schwartz DR, Carey TE (1991) Consistent chromosome abnormalities in squamous carcinoma of the vulva. Genes Chrom Cancer 3: 420–432.
- Worsham MJ, Kelker W, Van Dyke DL, Benninger M, James CD, Carey TE (1992) Molecular and cytogenetic evidence for loss of DCC in squamous cell cancer. Am J Hum Genet 50: A74.
- Worsham MJ, Benninger MJ, Zarbo RJ, Carey TE, Van Dyke DL (1993a) Deletion 9p22-pter and loss of Y as primary chromosome abnormalities in a squamous cell carcinoma of the vocal cord. Genes Chrom Cancer 6: 58–60.
- Worsham MJ, Carey TE, Benninger MS, Gasser KM, Kelker W, Zarbo RJ, Van Dyke DL (1993b) Clonal cytogenetic evolution in a squamous cell carcinoma of the skin from a xeroderma pigmentosum patient. Genes Chrom Cancer 7: 158–164.
- Worsham MJ, Carey TE, Benninger MS, Van Dyke DL (1993c) Squamous carcinomas of the head and neck are monoclonal, cytogenetically stable and exhibit minimal intratumor heterogeneity. Fifth International Workshop on Chromosomes in Solid Tumors, January 10-12, 1993, Tucson, Arizona.
- Yamaguchi T, Toguchida J, Yamamuro T, Kotura Y, Takada N, Kawaychi N, Kaneko Y, Nakamura Y, Sasaki MS, Ishizaki K (1992) Allelotype analysis in osteosarcomas: Frequent allele loss on 3q, 13q, 17p, and 18q. Cancer Res 52: 2419–2423.
- Yamamoto T, Kamata N, Kawano H, Shimizu S, Kuroki T, Toyoshima K, Rikimaru K, Nomura N, Ishizaki R, Pastan I, Gamou S, Shimizu N (1986) High incidence of amplification of epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res 46: 414–416.
- Yin XY, Donovan-Peluso M, Whiteside TL, Johnson JT, Day R, Herberman RB, Locker J (1991) Gene amplification and gene dosage in cell lines derived from squamous cell carcinoma of the head and neck. Genes Chrom Cancer 3: 443–454.
- Yokoyama S, Yamakawa K, Tsuchiya E, Murata M, Sakiyama S, Nakamura Y (1992) Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res 52: 873–477.